FAPI-PET bests FDG-PET in detecting gastrointestinal cancer
AuntMinnie
OCTOBER 31, 2023
Fibroblast activation protein inhibitor (FAPI)-PET/CT appears superior to standard FDG-PET/CT for detecting gastrointestinal cancer, with higher radiotracer uptake seen in most tumors, according to a study published October 26 in the Journal of Nuclear Medicine. In a clinical trial, researchers in Xiamen, China, compared the two approaches for detecting primary and metastatic tumors in patients with confirmed gastric, liver, or pancreatic cancer.
Let's personalize your content